ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $173,545 | +14.5% | 353 | -9.3% | 0.00% | +50.0% |
| Q2 2023 | $151,605 | +23.3% | 389 | +17.9% | 0.00% | 0.0% |
| Q1 2023 | $122,951 | +20.7% | 330 | +22.7% | 0.00% | 0.0% |
| Q4 2022 | $101,905 | +2.9% | 269 | -4.3% | 0.00% | 0.0% |
| Q3 2022 | $99,000 | -12.4% | 281 | -5.7% | 0.00% | 0.0% |
| Q2 2022 | $113,000 | +105.5% | 298 | +71.3% | 0.00% | +100.0% |
| Q1 2022 | $55,000 | +103.7% | 174 | +126.0% | 0.00% | – |
| Q4 2021 | $27,000 | +12.5% | 77 | -1.3% | 0.00% | – |
| Q3 2021 | $24,000 | – | 78 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |